Lennar Corp. CL B (LEN.B)$86.82
Currency: USD
Research Snapshot
Static fundamentals, valuation context, and investor signals for Lennar Corp. CL B (LEN.B).
DCF ready
Valuation
N/A
EV/FCF, N/A FCF yield
Quality
7.5%
ROIC, 0.1% FCF margin
Growth
8.7%
5Y sales (revenue) CAGR
Balance sheet
0.3x
Debt/equity, N/A current ratio
Superinvestors
4
Top: Third Avenue Management (1.9%)
Strengths to research
- Revenue compounded at 8.7% over five years.
- Debt/equity looks manageable at 0.3x.
- 4 tracked superinvestors report a position.
- 10 annual periods are available for trend analysis.
Watchouts
- Valuation multiples are limited or unavailable.
Annual data: 10 periods
Quarterly data: 24 periods
Stock snapshot: May 25, 2026
Static dataset: May 25, 2026
Quality Scorecard
Build-time composite score for LEN.B.
Grade D
31
/ 100
Financial Charts
No financial data available for LEN.B (annual).
4 superinvestors own LEN.B
Current quarter ownership and quarter-over-quarter share changes.
Superinvestor ownership
| Fund | Shares | Value | % Portfolio | QoQ Change |
|---|---|---|---|---|
| Greenhaven Associates Greenhaven Associates | 364,059 | $31M | 0.50% | 0.0% |
| Warren Buffett Berkshire Hathaway | 237,703 | $20M | 0.01% | 0.0% |
| Third Avenue Management Third Avenue Management | 142,843 | $12M | 1.95% | 0.0% |
| Samantha McLemore Patient Capital Management | 12,500 | $1M | 0.04% | 0.0% |